The FDA has accepted for Priority Review the sBLA for aflibercept injection 8mg for the treatment of macular edema following RVO and for monthly dosing in approved indications.

A case presentation involving a patient with severe, symptomatic iliofemoral deep vein thrombosis and need for urgent ...

In this expert perspective, Manjot K. Gill, MD, discusses faricimab for the management of retinal vein occlusion.

In this expert perspective, Manjot K. Gill, MD, discusses the potential FDA approval in 2025 of aflibercept 8 mg for the treatment of retinal vein occlusion.

Berlin: Bayer has submitted an application to the European Medicines Agency (EMA) seeking approval of aflibercept 8 mg (114.3 mg/ml solution for injection) for the treatment of patients with macular ...

Bayer seeks EMA approval to expand aflibercept 8 mg use for macular edema post retinal vein occlusion. Phase 3 QUASAR study data showed aflibercept 8 mg improved BCVA in patients with RVO, supporting ...

Background Recent studies support the effectiveness of mechanical thrombectomy (MT) for distal medium vessel occlusions (DMVOs). The RED 43 catheter has been introduced as a primary catheter for ...

Aim: To describe the prevalence and risk factors of retinal vein occlusion (RVO) in an Asian population. Methods: The Singapore Malay Eye Study is a population-based, cross-sectional study of 3280 (78 ...

Patients taking serotonin reuptake inhibitors or statins show less susceptibility for retinal vein occlusions, and SRIs can add to statins’ preventive effect. Serotonin reuptake inhibitor use is ...

The mediolateral diameter of the falcine sinus (FS) on fetal magnetic resonance imaging is a robust predictor of aggressive neonatal presentation requiring early treatment in vein of Galen ...

Damian Lillard has no timeline to return to the Milwaukee Bucks after being diagnosed with deep vein thrombosis in his right calf. The blood-clotting disorder also recently cut short Victor ...